help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahren, B.
Right arrow Articles by Taborsky, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahren, B.
Right arrow Articles by Taborsky, G. J., Jr

Endocrinology, Vol 118, 1551-1557, Copyright © 1986 by Endocrine Society


ARTICLES

The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog

B Ahren and GJ Taborsky Jr

The mechanism of vagal nerve stimulation of glucagon (IRG) and insulin (IRI) secretion was investigated in halothane-anesthetized dogs. Both ventral and dorsal branches of the thoracic vagi were stimulated electrically (10 Hz, 5 msec, 13.5 mA, 10 min) below the heart. Arterial and superior pancreaticoduodenal venous plasma were sampled, superior pancreaticoduodenal venous plasma flow was measured, and net pancreatic output of IRG and IRI were calculated. During vagal nerve stimulation (n = 15) net pancreatic output of IRG doubled (delta = +0.83 +/- 0.28 ng/min, P less than 0.01; baseline = 0.81 +/- 0.15 ng/ min) and IRI quadrupled (delta = +3.5 +/- 1.5 mU/min, P less than 0.025; baseline = 1.1 +/- 0.3 mU/min). Arterial glucose levels increased by 7 +/- 2 mg/dl from 108 +/- 3 mg/dl (P less than 0.005). After atropine pretreatment (n = 7), the pancreatic IRI response to vagal nerve stimulation was +0.71 +/- 0.28 mU/min (P less than 0.025), a reduction of 80%. In contrast, atropine pretreatment changed neither the IRG response (delta = +0.87 +/- 0.36 ng/min; P less than 0.05) nor the arterial glucose response (delta = +9 +/- 3 mg/dl; P less than 0.025) to vagal nerve stimulation. Hexamethonium pretreatment (n = 9) abolished the pancreatic IRG response (delta = +0.13 +/- 0.11 ng/min; NS), the arterial glucose response (delta = +0.5 +/- 1.9 mg/dl; NS) and the pancreatic IRI response (delta = +0.16 +/- 0.31 mU/min; NS) to vagal nerve stimulation. It is concluded that vagal nerve stimulation in the dog produces a moderate increase of IRG secretion, mediated by a nonmuscarinic (peptidergic?) mechanism, and a marked increase of IRI secretion, mediated by a muscarinic mechanism. Both responses are dependent on nicotinic transmission.


This article has been cited by other articles:


Home page
J EndocrinolHome page
J D Bailey, J G Berardinelli, T E Rocke, and R A Bessen
Prominent pancreatic endocrinopathy and altered control of food intake disrupt energy homeostasis in prion diseases
J. Endocrinol., May 1, 2008; 197(2): 251 - 263.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J Rozman and M Bunc
Modulation of visceral function by selective stimulation of the left vagus nerve in dogs
Exp Physiol, November 1, 2004; 89(6): 717 - 725.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Gilon and J.-C. Henquin
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function
Endocr. Rev., October 1, 2001; 22(5): 565 - 604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Benthem, T. O. Mundinger, and G. J. Taborsky Jr.
Parasympathetic inhibition of sympathetic neural activity to the pancreas
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E378 - E381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman
Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society